
Obesity Drug Stocks: Where to Invest Now
Eli Lilly and Novo Nordisk have staged big rallies. Here’s how investors can approach this potentially huge opportunity.
Diana Anghel is a member of the Morningstar Development Program and is on assignment with the Editorial department.









